TABLE 3.
T stage distribution for DAC and AAC
| Study | Tumour type | Total cases | T1 (%) | T2 (%) | T3 (%) | T4 (%) |
|---|---|---|---|---|---|---|
| Wu et al, 201740 | DAC | 511 | 103 (20.2) | 213 (41.0) | 115 (22.5) | 54 (10.6) |
| AAC | 3303 | 446 (13.5) | 2256 (68.3) | 522 (15.8) | 47 (1.4) | |
| Kim et al, 201555 | DAC | 29 | 16 (55.2) | 6 (20.7) | 7 (24.1) | |
| AAC | 116 | 68 (56.6) | 24 (19.9) | 28 (23.3) | ||
| Tarjan et al, 201229 | DAC | 13 | 1 (8.0) | 1 (8.0) | 10 (76.0) | 1 (8.0) |
| AAC | 97 | 49 (51.0) | 22 (23.0) | 26 (27.0) | 0 (0.0) | |
| Meeks et al, 20129 | DAC | 293 | 43 (14.7) | 110 (38.0) | 89 (30.3) | |
| AAC | 257 875 | 77 390 (30.0) | 123 919 (48.0) | 47 024 (18.0) | ||
| Morgan et al, 20107 | DAC | 324 | 130 (40.0) | 155 (48.0) | 39 (12.0) | |
| AAC | 414 587 | 187 893 (45.0) | 214 110 (52.0) | 12 584 (3.0) | ||
| Total | DAC | 1170 | 293(25.0) | 485 (41.5) | 260 (22.2) | 55 (10.5) |
| AAC | 675 978 | 265 846 (39.3) | 340 331 (50.4) | 60 184 (8.9) | 47 (1.4) | |
| RR | 0.88 (0.80‐0.97) | 0.74 (0.69‐0.79) | 1.71 (1.53‐1.91) | 7.56 (5.19‐11.01) | ||
| P value | P = .01 | P < .00001 | P < .00001 | P < .00001 |